AscellaHealth taps three home infusion pharmacies with preferred status

BERWYN, Pa. – AscellaHealth has announced that Amber Specialty Pharmacy, AcariaHealth and BioMatrix Specialty Pharmacy are preferred partners within its Home Infusion Pharmacy Network. These designations are part of AscellaHealth’s Site of Care Optimization initiative and overall strategies designed to cut costs without compromising quality of care. “By selecting these top pharmacies for preferred status, we are taking an important step toward reducing the cost of specialty biologic medications and encouraging patients to move from higher-cost settings, like big hospitals and institutions, to lower-cost settings, such as physician’s in-office infusion suites or stand-alone infusion centers,” says Dea Belazi, president and CEO, AscellaHealth. “As part of our mission to help our clients better manage the high costs of specialty medication, this initiative exemplifies our efforts to increase care accessibility by encouraging the use of clinically appropriate, lower-cost care settings. The extensive range of these pharmacy sites that are dedicated to infusion therapy creates a better patient experience and improves outcomes.” SOC optimization is particularly helpful for acute therapies, such as intravenous antibiotics or routine therapies for Crohn’s disease or rheumatoid arthritis, which can be safely and easily administered outside of the hospital or physician’s office settings. The goals are to: Improve drug affordability, increase price transparency, reduce disparities in quality of care and safety across care settings, enable care delivery in the highest-quality, lowest-cost care setting, and increase patient convenience for enhanced compliance to therapy.